SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-043243
Filing Date
2021-02-16
Accepted
2021-02-16 06:33:52
Documents
2
Group Members
CORRIENTE MASTER FUND II, LPMARK L. HART III

Document Format Files

Seq Description Document Type Size
1 SC 13G d100462dsc13g.htm SC 13G 77430
2 EX-99.A d100462dex99a.htm EX-99.A 3388
  Complete submission text file 0001193125-21-043243.txt   82364
Mailing Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107
Business Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107 8178700400
Corriente Advisors, LLC (Filed by) CIK: 0001406718 (see all company filings)

IRS No.: 752939516 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91311 | Film No.: 21632162
SIC: 2834 Pharmaceutical Preparations